New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: Emphasising that Lord Shree Jagannath is the supreme spiritual landlord of the Odia community,…
Bhubaneswar: The Annual High School Certificate (HSC) Examination 2026 began across Odisha on Wednesday, with…
Bhubaneswar: Sanatanpali, a quiet village under Jujumara block in Odisha’s Sambalpur district, today wears a…
Bhubaneswar: With a renewed thrust on accelerating grassroots development, Chief Secretary Anu Garg held an…
Bhubaneswar: Odisha took a major stride towards building an industry-aligned and future-ready skilling ecosystem with…
Bhubaneswar: Marking a new chapter in Odisha’s public transport system, the Capital Region Urban Transport…
